AKT1 and atherosclerosis: There is evidence that adropin, acting through the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) /mTOR signaling pathway, potentially protects against inflammation, oxidative damage, accelerating atherosclerosis and plaque formation [21].